… studies that have assessed HRQOL in MM patients have mainly focused on newly diagnosed
patients enrolled in randomized controlled trials (… the APEX trial, patients in the bortezomib …

… of patients with multiple myeloma (MM) using a systematic literature review and meta-analysis. …
Randomized controlled trials and observational studies that reported PFS or OS rates …

… rates in patients with previously untreated multiple myeloma who … placed on randomised
clinical trials, systematic reviews, meta… reported in the recent meta-analysis for lenalidomide-…

… Search criteria for systematic review. On 22 December 2015; … Randomized phase II study
of bortezomib, thalidomide, and … induction therapy in previously untreated multiple myeloma. J …

… for randomized controlled trials (RCTs) that included patients with multiple myeloma who …
and performed a random-effects meta-analysis to estimate the relative risk for infections. …

… clinical trials and new studies using novel agents such as thalidomide, lenalidomide and
bortezomib … (10) undertook a systematic review to identify all RCTs that addressed that question…

… our knowledge, although several systematic reviews and meta-… meta-analysis, trial sequential
analysis (TSA) and network … therapy with bortezomib plus thalidomide or bortezomib plus …

… III randomized control trial also explored the use of bortezomib as … patient meta-analysis of
these three upfront studies has … in patients with previously untreated multiple myeloma without …

… This systematic review is reported in accordance with the Preferred Reporting Items for
Systematic Reviews and … 37.3 62.7 Newly diagnosed multiple myeloma Bortezomib-lenalidomide-…

… Our meta-analysis demonstrates that in previously untreated, … thalidomide, lenalidomide
and bortezomib over the last … We performed a systematic review to integrate the existing …